A Phase I Trial of NECTAR (Nelarabine, Etoposide and Cyclophosphamide in T-ALL Relapse): A Joint Study of TACL POETIC and ITCC.
Phase of Trial: Phase I/II
Latest Information Update: 30 Sep 2017
At a glance
- Drugs Nelarabine (Primary) ; Cyclophosphamide; Etoposide; Methotrexate
- Indications Precursor cell lymphoblastic leukaemia-lymphoma; T cell lymphoma
- Focus Adverse reactions
- Acronyms NECTAR
- 23 Nov 2015 Status changed from recruiting to discontinued, as reported by ClinicalTrials.gov.
- 23 Dec 2014 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov record.
- 23 Dec 2014 Planned primary completion date changed from 1 Dec 2014 to 1 Dec 2016 as reported by ClinicalTrials.gov record.